Patent Litigation Weekly: Of IV, False-Marking, and Fighting Pay-for-Delay
This week: Intellectual Ventures gets a cash infusion for its non patent-enforcing business; a court decision says false-marking plaintiffs who sue over expired patents still have cases, but it will be tough to win; and Obama's DOJ makes its distaste for drug reverse-payment settlements clear.
By Joe Mullin|June 21, 2010
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.